Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Vitullo Nicole
Relationship:   10% Owner
City:   Richmond
State:   CA
   
Insider Summary:
  
   
Companies Owned :   26    
Direct Shares   3,769,432    

Indirect Shares

   2,643,947      
Direct Value   $41,780,389    

Indirect Value

   $8,970,540      
Total Shares   6,413,379      
Total Value   $50,750,929      


Onyx Pharmaceuticals Inc $0 Volcano Corp $0 Orexigen Therapeutics, Inc. $16 Esperion Therapeutics, Inc. $80,112 Aldeyra Therapeutics, Inc. $7,301,539 Marinus Pharmaceuticals Inc $9,921 Syndax Pharmaceuticals Inc $34,388,801 Onyx Pharmaceuticals Inc $0 Volcano Corp $0 Orexigen Therapeutics, Inc. $16 Esperion Therapeutics, Inc. $80,112 Aldeyra Therapeutics, Inc. $7,301,539 Marinus Pharmaceuticals Inc $9,921 Syndax Pharmaceuticals Inc $34,388,801
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -29.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Nuvasive Inc NUVA 10% Owner 0 2004-05-12 8,000    Premium*  
            Onyx Pharmaceuticals Inc ONXX Director 2005-07-28 668 2005-07-28 0    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 0 2006-12-21 19,379    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 2006-04-18 0 2006-12-12 21,068    Premium*  
            Northstar Neuroscience Inc NSTR 10% Owner 0 2006-05-04 3,333    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 0 2006-05-09 100,355    Premium*  
            Cadence Pharmaceuticals Inc CADX 10% Owner 0 2014-03-19 0    Premium*  
            Volcano Corp VOLC 10% Owner 2008-04-28 5,142 2008-04-24 56,718    Premium*  
            Orexigen Therapeutics, Inc. OREX 10% Owner 2007-11-27 3,019 2011-12-22 50,643    Premium*  
            Alimera Sciences Inc ALIM 10% Owner 2010-04-27 0 2011-06-02 40,790    Premium*  
            Achillion Pharmaceuticals Inc ACHN Director 2020-01-28 0 2020-01-28 0    Premium*  
            Zogenix, Inc. ZGNX 10% Owner 2010-11-29 0 2011-09-16 169,251    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2011-11-21 0 2011-11-21 51,013    Premium*  
            Durata Therapeutics, Inc. DRTX Director, 10% Owner 0 2012-07-24 22,306    Premium*  
            Esperion Therapeutics, Inc. ESPR Director 2023-06-15 36,918 2019-03-21 0    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2017-12-11 0 2013-07-15 1,920,730    Premium*  
            Tobira Therapeutics Inc TBRA 10% Owner 2016-11-01 0 2013-08-27 32,091    Premium*  
            Evoke Pharma Inc EVOK 10% Owner 0 2013-09-30 24,256    Premium*  
            Veracyte, Inc. VCYT 10% Owner 2013-11-04 0 2013-11-04 22,730    Premium*  
            Tandem Diabetes Care Inc TNDM 10% Owner 2013-11-19 0 2013-11-19 54,390    Premium*  
            Dicerna Pharmaceuticals Inc DRNA 10% Owner 2014-02-04 0 2014-02-04 13,004    Premium*  
            Achaogen Inc AKAO 10% Owner 2014-03-17 0 2014-03-17 33,890    Premium*  
            Aldeyra Therapeutics, Inc. ALDX 10% Owner 2014-05-07 1,973,389 2014-05-01 0    Premium*  
            Marinus Pharmaceuticals Inc MRNS Director 2022-02-04 6,442 2021-03-16 0    Premium*  
            Colucid Pharmaceuticals, Inc. CLCD 10% Owner 2016-09-09 0 0    Premium*  
            Syndax Pharmaceuticals Inc SNDX 10% Owner 2016-03-08 1,743,854 2016-03-08 0    Premium*  
* Premium Members only  

Records found :    164         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ESPR Esperion Therapeutics, In... Director   –       •      –    2019-03-21 4 A $0.00 $0 D/D 1,356 8,319 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2019-05-29 4 A $0.00 $0 D/D 4,967 13,286 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2020-05-28 4 A $0.00 $0 D/D 6,106 19,392 0 -
MRNS Marinus Pharmaceuticals I... Director   –       •      –    2021-03-12 4 A $0.00 $0 I/I 6,192 6,192 0 -
MRNS Marinus Pharmaceuticals I... Director   –       •      –    2021-03-16 4 A $0.00 $0 D/D 2,717 3,692 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2021-05-27 4 A $0.00 $0 D/D 12,376 31,768 0 -
MRNS Marinus Pharmaceuticals I... Director   –       •      –    2022-02-04 4 A $0.00 $0 D/D 2,750 6,442 0 -
ESPR Esperion Therapeutics, In... Director   –       •      –    2023-06-15 4 A $0.00 $0 D/D 5,150 36,918 0 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2008-12-08 4 B $4.47 $1,110,397 I/I 248,411 4,173 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2008-12-09 4 B $4.93 $1,192,518 I/I 241,890 8,237 1.5 -
CADX Cadence Pharmaceuticals I... 10% Owner   –       –       •   2009-02-18 4 B $7.13 $19,826,206 I/I 2,780,674 46,634 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-07-23 4 B $7.50 $4,875,000 I/I 650,000 19,138 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-08-11 4 B $7.60 $792,680 I/I 104,300 20,887 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-08-12 4 B $8.00 $3,200,000 I/I 400,000 27,595 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-08-13 4 B $7.85 $102,050 I/I 13,000 27,813 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-08-14 4 B $8.00 $209,800 I/I 26,225 28,253 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-08-17 4 B $7.64 $482,856 I/I 63,201 29,313 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-11-10 4 B $6.93 $584,892 I/I 84,400 30,959 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-11-11 4 B $6.93 $371,448 I/I 53,600 31,858 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-11-12 4 B $6.90 $427,800 I/I 62,000 32,898 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-11-20 4 B $6.93 $1,732,500 I/I 250,000 37,090 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-11-23 4 B $6.93 $1,039,500 I/I 150,000 39,606 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-11-24 4 B $6.75 $337,500 I/I 50,000 40,445 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-12-17 4 B $7.55 $755,000 I/I 100,000 42,122 1.5 -
OREX Orexigen Therapeutics, In... 10% Owner   –       –       •   2009-12-18 4 B $7.50 $285,750 I/I 38,100 42,761 1.5 -
  164  Records found
  1   2   3  4   5   6   7      
  Page 3 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us